Uncontrolled Cell Growth and Human Health: A Comprehensive Exploration of Cancer

Year : 2026 | Volume : 15 | Issue : 01 | Page : 1 23
    By

    V. Basil Hans,

  1. Research Professor, Department of Management and Commerce, Srinivas University, Mangalore, Karnataka, India

Abstract

Cancer is a diverse category of diseases defined by the uncontrolled proliferation and spread of aberrant cells. It remains the major cause of morbidity and mortality worldwide. This article presents an overview of the various forms of cancer, such as carcinomas, sarcomas, lymphomas, and leukaemia, emphasising their distinct causes, symptoms, and risks. Early detection and diagnosis are emphasized as key to enhancing treatment outcomes. The article further provides an in-depth discussion of the wide spectrum of therapeutic remedies and treatment modalities currently employed in cancer management. Conventional treatment approaches, such as surgical excision, chemotherapy, and radiation therapy, are explained in detail, highlighting their roles, indications, and limitations in different stages and types of cancer. In addition, the article explores advanced and emerging treatment strategies, including immunotherapy and targeted therapy, which aim to enhance treatment precision by selectively attacking cancer cells while minimizing damage to normal tissues. Novel approaches, such as gene therapy and personalized medicine, are also examined, emphasizing their potential to tailor treatments based on an individual’s genetic profile and tumor characteristics, thereby improving clinical outcomes. Furthermore, the article addresses the importance of lifestyle modifications and preventive measures, including healthy dietary practices, regular physical activity, avoidance of tobacco and excessive alcohol consumption, and early screening programs, in reducing cancer risk. By integrating recent scientific evidence and ongoing advancements in cancer research, this article aims to provide readers with a comprehensive understanding of cancer types, current therapeutic options, and evolving strategies for effective management and potential cure.

Keywords: Cancer, types of cancer, cancer treatment, early detection, preventive measures

[This article belongs to Research and Reviews: Journal of Oncology and Hematology ]

How to cite this article:
V. Basil Hans. Uncontrolled Cell Growth and Human Health: A Comprehensive Exploration of Cancer. Research and Reviews: Journal of Oncology and Hematology. 2026; 15(01):1-23.
How to cite this URL:
V. Basil Hans. Uncontrolled Cell Growth and Human Health: A Comprehensive Exploration of Cancer. Research and Reviews: Journal of Oncology and Hematology. 2026; 15(01):1-23. Available from: https://journals.stmjournals.com/rrjooh/article=2026/view=241131


References

  1. Wang S, Liu Y, Feng Y, Zhang J, Swinnen J, Li Y, et al. A review of cancer curability: Additional efforts for novel therapeutic options are required. Cancer Manag Res. 2019;11:10397–10409.
  2. Virani K. A discrete model of cancer tumour growth and treatment effects. New York: City University of New York (CUNY); 2016.
  3. Kaul P, Choudhary D, Tiwari AR, Walia R, Sadhu S, Garg PK. A cross-sectional study of the most common myths and misconceptions among cancer patients’ carers. J Cancer Educ. 2023;38(3):1031–1037.
  4. Souto EB, da Ana R, Vieira V, Fangueiro JF, Dias-Ferreira J, Cano A, et al. Non-melanoma skin cancers: Physiopathology and the significance of lipid delivery systems in novel chemotherapeutic therapies. Pharmaceutics. 2022;14(3):553.
  5. Bleloch JS, Ballim RD, Kimani S, Parkes J, Panieri E, Willmer T, et al. Managing sarcoma: Where have we come from and where are we going? Ther Adv Med Oncol. 2017;9(10):637–659.
  6. Salama M, Aborehab N, El Mahdy N, Zayed A, Ezzat SM. Nanotechnology in leukaemia: Diagnosis, tailored drug administration, and clinical trials. Pharmaceutics. 2023;15(2):457.
  7. Turaliu M, Sava LG, Goan CM, Budu VA. Therapeutic approaches for treating malignant lymphomas of the head and neck. Arch Balk Med Union. 2018;53(3):454–458.
  8. Abdullah Z, Zaaba SK, Mustaffa MT, Mohamad CWSR, Mohtar JA. A review of cold atmospheric plasma treatment for melanoma skin cancer. J Telecommun Electron Comput Eng. 2018;10(1–17):125–130.
  9. Dasgupta P, Cameron JK, Cramb SM, Trevithick R, Aitken JF, Mengersen K, et al. Geographic and spatial inequalities in the incidence and survival rates of uncommon malignancies in Australia. Cancer Epidemiol. 2023;83:102346.
  10. Kondo T. Current and future outlook for patient-derived cancer models in rare cancer research. Cells. 2021;10(1):90.
  11. Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, et al. Cancer symptoms and stage at diagnosis: Findings from a cross-sectional population-based study. Lancet Oncol. 2020;21(1):73–79.
  12. Zubair M, Wang S, Ali N. Advanced methods for breast cancer classification and diagnosis. Cancers (Basel). 2021;13(11):2852.
  13. Khanna D, Khargekar NC, Khanna AK. Implementation of early cancer detection services in India during the COVID-19 pandemic. Asian Pac J Cancer Prev. 2020;21(10):2925–2930.
  14. Messadi DV. Diagnostic aids for detecting oral precancerous diseases. Int J Oral Sci. 2013;5(2):59–65.
  15. Debela DT, Muzazu SGY, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current viewpoints. J Oncol. 2021;2021:1–13.
  16. Collins C, editor. Radiation therapy medical physics review: Delivery, interactions, safety, feasibility, and head-to-head comparisons of the leading radiation therapy techniques. Durham: University of New Hampshire; 2017. Available from: https://scholars.unh.edu/honors/377
  17. Kumar S, Choudhary S, Singh N, Setty M. Combination of natural drugs: An emerging trend in cancer chemotherapy. J Drug Deliv Ther. 2012;2(3):111–116.
  18. Yang L, Ning Q, Tang S. Recent advances and the next breakthrough in cancer immunotherapy. J Hematol Oncol. 2022;15:130.
  19. Leong PP, Seow HF. Cancer immunotherapy: Current developments and uses. Oncology. 2006;70(5):395–405.
  20. Seebacher N, Stacy AE, Porter GM, Merlot AM. Clinical trials of targeted and immune-based anticancer treatments. Int J Mol Sci. 2019;20(15):3643.
  21. Araghi M, Mannani R, Heidarnejad Maleki A, Hamidi A, Rostami S, Hozhabri Safa S, et al. Recent breakthroughs in non-small cell lung cancer targeted therapy: An update review. Cancers (Basel). 2023;15(5):1396.
  22. Imtiaz I, Schloss J, Bugarcic A. A scoping review of traditional and current herbal medications used to treat cancer. J Integr Med. 2024;22(2):89–102.
  23. Ahmad A, Ginnebaugh KR, Li Y, Padhye SB, Sarkar FH. Molecular targets of naturopathy in cancer research: A link to modern medicine. Nutrients. 2015;7(5):3219–3249.
  24. Chandwani KD, Ryan JL, Peppone LJ, Janelsins MC, Sprod LK, Devine K, et al. Cancer-related stress and complementary and alternative medicine: A review. J Altern Complement Med. 2012;18(10):928–936.
  25. Mayden KD. Mind-body therapies: Evidence and implications for advanced oncology practice. Clin J Oncol Nurs. 2012;16(6):670–677.
  26. Chasen MR, Dippenaar AP. Cancer nutrition and rehabilitation: The time has arrived. Curr Oncol. 2008;15(5):241–243.
  27. Cardoso DH, Muniz RM, Guimarães SRL, Viegas AC, Pinto BK, Laroque MF. Living with cancer: The perspective of oncology patients. Rev Gaucha Enferm. 2013;34(3):111–117.
  28. Elsheshtawy EA, Abo-Elez WF, Ashour HS, Farouk O, El Zaafarany MIE. Coping strategies in Egyptian women with breast cancer. Breast Cancer (Dove Med Press). 2014;6:57–62.
  29. Dev R, Agosta M, Fellman B, Reddy A, Baldwin S, Arthur J, et al. Coping strategies and symptom burden among patients with advanced cancer. J Pain Symptom Manage. 2023;65(4):e371–e380.
  30. Rutledge R, Robinson L. Community-based organisations play crucial roles in providing comprehensive cancer care. Eur J Cancer Care (Engl). 2009;18(6):522–528.
  31. Henshall CL, Greenfield SM, Gale NK. Typologies for restructuring relationships in cancer survivorship: Temporal changes in social support and self-management practices. Cancer Nurs. 2018;41(6):E32–E40.
  32. Alt-Epping B, Pache S, Lindena G, Nauck F. Anticancer treatments in specialised palliative care: A multicenter survey. Support Care Cancer. 2011;19(12):2061–2067.
  33. Upadhyay A. Cancer: An unknown territory; reconsider before proceeding. Indian J Med Ethics. 2020;5(2):135–138.
  34. Dembic Z. Anti-tumor drugs and their targets. Molecules. 2020;25(18):4367.
  35. Kalin A. Improving cancer treatment delivery to reduce side effects. New York: Columbia University; 2012.
  36. Latha ST. Identifying and isolating bioactive constituents from Gomphrena globosa aerial parts for cancer therapy. Chennai: Tamil Nadu Dr. M.G.R. Medical University; 2013.
  37. McKendrick J. Treatment for cancer. Eur J Cancer. 2014;50(1):1–4.
Regular Issue Subscription Book Review
Volume 15
Issue 01
Received 16/01/2026
Accepted 09/02/2026
Published 05/04/2026
Publication Time 79 Days
10

Login


My IP

PlumX Metrics